Navigation Links
Hyaluron Contract Manufacturing Named a 2007 Economic Impact Award Finalist
Date:9/10/2007

HCM recognized by Massachusetts Alliance for Economic Development on the

basis of its strong contribution to Massachusetts economy

BURLINGTON, Mass., Sept. 10 /PRNewswire/ -- Hyaluron Contract Manufacturing (HCM), a leading provider of aseptic manufacturing services to companies in the pharmaceutical and biotechnology industries, announced today that it has been selected as a finalist for the 2007 Team Massachusetts Economic Impact Award. HCM is one of five companies from the greater Boston area that is being considered for this award based on its strong contribution to the Massachusetts economy since January 1, 2006.

"We are extremely pleased to be among the finalists for this award," stated Shawn Kinney, President of HCM. "To be considered along with some of the other finalists as well as past winners is quite an honor for us."

Since January of 2006, HCM has experienced significant growth, making it one of the fastest growing biotech manufacturers in the Commonwealth. In that time, HCM has invested over 2.25 million in facility expansion and has created nearly forty new jobs bringing its current headcount to eighty-five. In October of 2006, the company applied for a patent on its unique Bubble-free filling(TM) technology designed to reduce or eliminate the bubble inside a prefilled syringe.

HCM's future plans include the expansion of its current facility by at least 6,000 square feet and the addition of several new jobs, bringing the total number of employees to 100 by the end of 2007.

In its fourth year, the Team Massachusetts Economic Impact Award recognizes companies from across the Commonwealth for their outstanding contribution to the Massachusetts economy based on job and facility expansion as well as product launch and community involvement. Past winners include Boston Scientific, Bayer Diagnostics, and Wyeth Biopharmaceuticals.

About HCM:

Hyaluron Contract Manufacturing (HCM) is a leader in aseptic contract manufacturing of filled liquid parenterals and medical devices. Since 1999, HCM has been offering its customers-from newly established firms to large- scale commercial enterprises-innovative and unique solutions to all their aseptic formulation/fill needs. At the core of HCM's business is a commitment to quality, regulatory compliance and on-time delivery. HCM is located in Burlington MA. For further information, visit http://www.hyaluron.com.

Hyaluron Contract Manufacturing, Inc.

99 South Bedford Street

Burlington, MA 01803

Contact: Claudio Tracanna

Office Phone 781-270-7900 x 114

Cell Phone: 781-443-2850

Email ctracanna@hyaluron.com


'/>"/>
SOURCE Hyaluron Contract Manufacturing, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Small Tree Communications awarded $2.85M defense contract
2. Research consortium aims to bring security and defense contracts to Wisconsin
3. Johnson Controls unit lands contract for plug-in hybrid battery
4. Johnson Controls partnership wins new contract
5. Defense contract helps Plexus gain record profits
6. Orbitec will use $25 million Air Force contract to make small launch vehicle
7. WHIE receives state eHealth Initiative contract
8. State defensive on new Oracle contract
9. Fisher Biosciences contracts with Madison-based GenTel BioSurfaces
10. School districts contract with Lawson for new data processing software
11. Doyle says new contracts saving state more than $16 million annually
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... DIEGO , June 24, 2016 ... more sensitively detects cancers susceptible to PARP inhibitors ... circulating tumor cells (CTCs). The new test has ... HRD-targeted therapeutics in multiple cancer types. ... targeting DNA damage response pathways, including PARP, ATM, ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering ... retention in this eBook by providing practical tips, tools, and strategies for clinical ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. ... test has received AOAC Research Institute approval 061601. , “This is another AOAC-RI ... stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate ...
Breaking Biology Technology:
(Date:5/16/2016)... , May 16, 2016   EyeLock LLC , ... announced the opening of an IoT Center of Excellence ... and expand the development of embedded iris biometric applications. ... level of convenience and security with unmatched biometric accuracy, ... identity aside from DNA. EyeLock,s platform uses video technology ...
(Date:5/9/2016)... -- Elevay is currently known as the ... high net worth professionals seeking travel for work   ... there is still no substitute for a face-to-face meeting. ... deal with a firm handshake. This is why wealthy ... citizenship via investment programs like those offered by the ...
(Date:4/28/2016)... , April 28, 2016 Infosys ... (NYSE: INFY ), and Samsung SDS, a global ... that will provide end customers with a more secure, fast ...      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) , ... but it also plays a fundamental part in enabling and ...
Breaking Biology News(10 mins):